Home Tags Colorectal cancer
Tag: colorectal cancer
The mouth microbiota may be used as a potential biomarker and target for the diagnosis and treatment of colorectal cancer. A new study pulished in Cell Reports claims.
The alterations in gut microbiota composition observed in mice lacking TAK1 can generate a protective immunity against colitis and colorectal cancer.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.
Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
Researchers from the University of Trento have found that specific changes in gut microbiota composition are associated with colorectal cancer.
Scientists may have just figured out how colibactin, a DNA-damaging molecule produced by certain strains of E. coli, contributes to colorectal cancer.